Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
51
datasets available to search
ShareScore release 0.9.0
Dataset results
51 results for “plexiform neurofibroma”
Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabraf
ClinicalTrials.gov study NCT02124772. IPD Sharing: YES. Countries: 5. Publications: 3.
MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas
ClinicalTrials.gov study NCT03962543. IPD Sharing: YES. Countries: 1. Publications: 1.
Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults
ClinicalTrials.gov study NCT02101736. IPD Sharing: Not stated. Countries: 1. Publications: 2.
R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
ClinicalTrials.gov study NCT00021541. IPD Sharing: NO. Countries: 2. Publications: 4.
Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas
ClinicalTrials.gov study NCT03231306. IPD Sharing: NO. Countries: 1. Publications: 24.
Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas
ClinicalTrials.gov study NCT04924608. IPD Sharing: YES. Countries: 13. Publications: 1.
Study of PEG-Intron for Plexiform Neurofibromas
ClinicalTrials.gov study NCT00396019. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas
ClinicalTrials.gov study NCT01673009. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
ClinicalTrials.gov study NCT00076102. IPD Sharing: NO. Countries: 1. Publications: 4.
Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1
ClinicalTrials.gov study NCT02211768. IPD Sharing: YES. Countries: 1. Publications: 3.
A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)
ClinicalTrials.gov study NCT04590235. IPD Sharing: YES. Countries: 1. Publications: 0.
Low-dose Selumetinib for the Treatment of Plexiform Neurofibromas in Chinese Children
ClinicalTrials.gov study NCT06763315. IPD Sharing: NO. Countries: 1. Publications: 6.
Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas
ClinicalTrials.gov study NCT05101148. IPD Sharing: YES. Countries: 4. Publications: 1.
MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas
ClinicalTrials.gov study NCT02407405. IPD Sharing: YES. Countries: 1. Publications: 3.
Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas
ClinicalTrials.gov study NCT01412892. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
ClinicalTrials.gov study NCT00340522. IPD Sharing: Not stated. Countries: 1. Publications: 3.
PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma
ClinicalTrials.gov study NCT00253474. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Systematically Assessing Changes in Plexiform Neurofibroma Related Disfigurement From Photographs of Subjects With Neurofibromatosis Type 1 on a Phase 2 Clinical Trial
ClinicalTrials.gov study NCT04879160. IPD Sharing: YES. Countries: 1. Publications: 1.
Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas
ClinicalTrials.gov study NCT00727233. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas
ClinicalTrials.gov study NCT01275586. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.